Relative to focal segmental glomerulosclerosis.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 5 Sponsors

Jun 11, 2026 · Assembly

Coauthors revised.

Jun 11, 2026 · Assembly

Read. Adopted. (Ayes 74. Noes 0. Page 5671.).

Jun 4, 2026 · Assembly

From committee: Be adopted. To Consent Calendar. (Ayes 9. Noes 0.) (June 4).

May 26, 2026 · Assembly

Referred to Com. on RLS.

May 18, 2026 · Assembly

Introduced.

PASSAGE PROBABILITY

43.9% Uncertain

Why this number

Stage base Passed First Chamber — base rate 56%, measured from CA's completed sessions
Momentum +4 70/100 from the pace of recorded action
Time since last action -17 123 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.